Drug-induced angioedema without urticaria: Prevalence and clinical features

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 6, 2010, Pages 685-691

  Leeyaphan, C ^a   Kulthanan, K ^a   Jongjarearnprasert, K ^a   Dhana, N ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Angioedema; Clinical features; Drug induced; Prevalence

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; AZITHROMYCIN; CEFTRIAXONE; CELECOXIB; CIMETIDINE; CIPROFLOXACIN; CORTICOSTEROID; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPERISONE; ETORICOXIB; GABAPENTIN; IBUPROFEN; LEUPRORELIN; MEFENAMIC ACID; MELOXICAM; MUSCLE RELAXANT AGENT; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NORFLOXACIN; PARACETAMOL; PIROXICAM; ROXITHROMYCIN; TENOXICAM; UNINDEXED DRUG; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL FEATURE; DISEASE DURATION; DRUG INDUCED DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URTICARIA; AGED; ANGIOEDEMA; CHEMICALLY INDUCED; KAPLAN MEIER METHOD; MIDDLE AGED; THAILAND; TIME;

ADULT; AGED; ANGIOEDEMA; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; THAILAND; TIME FACTORS; URTICARIA;

EID: 77952145111     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03489.x     Document Type: Article

References (57)

1. Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol 2005 53 : 373 388.
2. Kulthanan K, Jiamton S, Boochangkool K, Jongjarearnprasert K. Angioedema: clinical and etiological aspects. Clin Dev immunol 2007 2007 : 26438.
3. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 2001 24 : 599 606.
4. Naldi L, Conforti A, Venegoni M et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999 48 : 839 846.
5. Patel RM, Marfatia YS. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol 2008 74 : 430.
6. Zembowicz A, Mastalerz L, Setkowicz M et al. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol 2003 139 : 1577 1582.
7. Quercia O, Emiliani F, Foschi FG, Stefanini GF. Safety of etoricoxib in patients with reactions to NSAIDs. J Investig Allergol Clin Immunol 2008 18 : 163 167.
8. Colanardi MC, Nettis E, Traetta P et al. Safety of parecoxib in patients with nonsteroidal anti-inflammatory drug-induced urticaria or angioedema. Ann Allergy Asthma Immunol 2008 100 : 82 85.
9. Celik G, Pasaoglu G, Bavbek S et al. Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance. J Asthma 2005 42 : 127 131. (Pubitemid 40570818)
10. Andri L, Falagiani P. Safety of celecoxib in patients with cutaneous reactions due to ASA-NSAIDs intolerance. Allergol Immunopathol 2007 35 : 126 129.
11. Atzori L, Pinna AL, Pau M, Aste N, Zucca M, Ferreli C. Adverse cutaneous reactions to selective cyclooxygenase 2 inhibitors: experience of an Italian drug-surveillance center. J Cutan Med Surg 2006 10 : 31 35.
12. Downing A, Jacobsen J, Sorensen HT et al. Risk of hospitalization for angio-oedema among users of newer COX-2 selective inhibitors and other nonsteroidal anti-inflammatory drugs. Br J Clin Pharmacol 2006 62 : 496 501.
13. Bavbek S, Celik G, Pasaoglu G, Misirligil Z. Rofecoxib, as a safe alternative for acetyl salicylic acid/nonsteroidal anti-inflammatory drug-intolerant patients. J Investig Allergol Clin Immunol 2006 16 : 57 62.
14. Nettis E, Colanardi MC, Ferrannini A et al. Short-term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2005 95 : 438 442. (Pubitemid 41688505)
15. Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. Ann Allergy Asthma Immunol 2005 95 : 154 158.
16. Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib. Ann Allergy Asthma Immunol 2005 94 : 34 38.
17. Rudolf J, Grond M, Schmulling S et al. Orolingual angioneurotic edema following therapy of acute ischemic stroke with alteplase. Neurology 2000 55 : 599 600.
18. Cooper JP, Quarry DP, Beale DJ, Chappell AG. Life-threatening, localized angio-oedema associated with streptokinase. Postgrad Med J 1994 70 : 592 593.
19. Pancioli A, Brott T, Donaldson V, Miller R. Asymmetric angioneurotic edema associated with thrombolysis for acute stroke. Ann Emerg Med 1997 30 : 227 229.
20. Walls RM, Pollack CV Jr. Successful cricothyrotomy after thrombolytic therapy for acute myocardial infarction: a report of two cases. Ann Emerg Med 2000 35 : 188 191.
21. Hill MD, Barber PA, Takahashi J et al. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. CMAJ 2000 162 : 1281 1284.
22. Sauve L, Gras-Champel V, Decocq G et al. Angioedema associated with the use of dihydropyridines. Therapie 1999 54 : 64 65.
23. Burches E, Garcia-Verdegay F, Ferrer M, Pelaez A. Amiodarone-induced angioedema. Allergy 2000 55 : 1199 1200.
24. Beyens MN, Guy C, Mounier G et al. Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. Drug Saf 2008 31 : 1017 1026.
25. Gencer S, Ozer S, Demirhan G et al. Angio-oedema as an unusual tolerable side effect of voriconazole therapy. J Med Microbiol 2008 57 : 1028 1031.
26. Krikorian RK, Quick A, Tal A. Angioedema following the intravenous administration of metoprolol. Chest 1994 106 : 1922 1923.
27. Cooney C, Nagy A. Angio-oedema associated with risperidone. Br Med J 1995 311 : 1204.
28. Mithani H, Hurwitz TA. Paroxetine-induced angioedema and tongue swelling. J Clin Psychiatry 1996 57 : 486.
29. Kimyai-Asadi A, Harris JC, Nousari HC. Critical overview: adverse cutaneous reactions to psychotropic medications. J Clin Psychiatry 1999 60 : 714 725.
30. World Health Organization. Causality Assessment of Suspected Adverse Reactions. URL http://www.who-umc.org/DynPage.aspx?id=22682 (last accessed: 23 June 2009).
31. Settipane GA. Aspirin and allergic diseases: a review. Am J Med 1983 74 : 102 109.
32. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. Cutaneous reactions to aspirin and nonsteroidal antiinflammatory drugs. Clin Rev Allergy Immunol 2003 24 : 125 136.
33. Banerji A, Oren E, Hesterberg P et al. Ten-year study of causes of moderate to severe angioedema seen by an inpatient allergy/immunology consult service. Allergy Asthma Proc 2008 29 : 88 92.
34. Quiralte J, Blanco C, Castillo R et al. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996 98 : 678 685.
35. Grossman E, Messerli FH, Neutel JM. Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors? Arch Intern Med 2000 160 : 1905 1911.
36. Kostis JB, Kim HJ, Rusnak J et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 2005 165 : 1637 1642.
37. Sondhi D, Lippmann M, Murali G. Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema: clinical experience at a large community teaching hospital. Chest 2004 126 : 400 404.
38. Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 1996 60 : 8 13.
39. Malde B, Regalado J, Greenberger PA. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Ann Allergy Asthma Immunol 2007 98 : 57 63.
40. Arakawa M, Murata Y, Rikimaru Y, Sasaki Y. Drug-induced isolated visceral angioneurotic edema. Intern Med 2005 44 : 975 978.
41. Jacobs RL, Hoberman LJ, Goldstein HM. Angioedema of the small bowel caused by an angiotensin-converting enzyme inhibitor. Am J Gastroenterol 1994 89 : 127 128.
42. Byrne TJ, Douglas DD, Landis ME, Heppell JP. Isolated visceral angioedema: an underdiagnosed complication of ACE inhibitors? Mayo Clin Proc 2000 75 : 1201 1204.
43. Sabroe RA, Black AK. Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema. Br J Dermatol 1997 136 : 153 158.
44. Vichyanond P, Sunthornchart S, Singhirannusorn V et al. Prevalence of asthma, allergic rhinitis and eczema among university students in Bangkok. Respir Med 2002 96 : 34 38.
45. Ueno T, Kawana S. A case of eperisone hydrochloride (myonal)-induced drug eruption leading to erythema and angioedema. Arerugi 2007 56 : 709 713.
46. Ribi C, Vermeulen C, Hauser C. Anaphylactic reactions to tolperisone (Mydocalm). Swiss Med Wkly 2003 133 : 369 371.
47. Desaphy JF, Dipalma A, De Bellis M et al. Involvement of voltage-gated sodium channels blockade in the analgesic effects of orphenadrine. Pain 2009 142 : 225 235.
48. Labout JJ, Thijssen C, Keijser GG, Hespe W. Difference between single and multiple dose pharmacokinetics of orphenadrine hydrochloride in man. Eur J Clin Pharmacol 1982 21 : 343 350.
49. Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage 2004 28 : 140 175.
50. Frank MM. Hereditary angioedema. J Allergy Clin Immunol 2008 121 : S398 S401.
51. Binkley KE, Davis A III. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 2000 106 : 546 550.
52. Warin RP, Cunliffe WJ, Greaves MW, Wallington TB. Recurrent angioedema: familial and oestrogen-induced. Br J Dermatol 1986 115 : 731 734.
53. Serrano C, Guilarte M, Tella R et al. Oestrogen-dependent hereditary angio-oedema with normal C1 inhibitor: description of six new cases and review of pathogenic mechanisms and treatment. Allergy 2008 63 : 735 741.
54. Andre C, Andre F, Veysseyre-Balter C, Rousset H. Acquired angioneurotic edema induced by hormonal contraception. Presse Med 2003 32 : 831 835.
55. Leung R, Plomley R, Czarny D. Paracetamol anaphylaxis. Clin Exp Allergy 1992 22 : 831 833.
56. Ayonrinde OT, Saker BM. Anaphylactoid reactions to paracetamol. Postgrad Med J 2000 76 : 501 502.
57. Liao CM, Chen WC, Lin CY. Study of an anaphylactoid reaction to acetaminophen. Acta Paediatr Taiwan 2002 43 : 147 152.